Search

Your search keyword '"Shamiss A"' showing total 427 results

Search Constraints

Start Over You searched for: Author "Shamiss A" Remove constraint Author: "Shamiss A"
427 results on '"Shamiss A"'

Search Results

3. PO-01-020 PERI-OPERATIVE AMIODARONE PROPHYLAXIS IN CARDIOVASCULAR SURGERY: IMPACTS ON POST-OPERATIVE LENGTH OF STAY ACCORDING TO PROCEDURE TYPES

4. PO-01-018 PRE-OPERATIVE DISCONTINUATION OF NOVEL ORAL ANTICOAGULANTS IN CARDIOVASCULAR SURGERY: IS TWO DAYS ENOUGH?

5. PO-01-019 PRE-OPERATIVE DISCONTINUATION OF NOVEL ORAL ANTICOAGULANTS IN CARDIOVASCULAR SURGERY: HOLD TIME IS ASSOCIATED WITH LENGTH OF STAY

7. PO-01-018 PRE-OPERATIVE DISCONTINUATION OF NOVEL ORAL ANTICOAGULANTS IN CARDIOVASCULAR SURGERY: IS TWO DAYS ENOUGH?

8. PO-01-020 PERI-OPERATIVE AMIODARONE PROPHYLAXIS IN CARDIOVASCULAR SURGERY: IMPACTS ON POST-OPERATIVE LENGTH OF STAY ACCORDING TO PROCEDURE TYPES

13. Hypertension in late adolescence and cardiovascular mortality in midlife: a cohort study of 2.3 million 16- to 19-year-old examinees

15. PO-01-019 PRE-OPERATIVE DISCONTINUATION OF NOVEL ORAL ANTICOAGULANTS IN CARDIOVASCULAR SURGERY: HOLD TIME IS ASSOCIATED WITH LENGTH OF STAY

20. Cost considerations in the management of atrial fibrillation – impact of dronedarone

21. Population Screening Using Sewage Reveals Pan-Resistant Bacteria in Hospital and Community Samples.

22. Clinical outcomes and cost effectiveness of accelerated diagnostic protocol in a chest pain center compared with routine care of patients with chest pain.

26. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

27. PERIOPERATIVE MANAGEMENT OF ORAL ANTICOAGULANTS IN CARDIAC SURGERY, WHEN IS THE OPTIMAL STOP TIME

28. White blood cell count and the risk for coronary artery disease in young adults.

30. Cost of AF Ablation: Where Do We Stand?

46. Association of Adolescent Hypertension With Future End-stage Renal Disease

47. PERIOPERATIVE MANAGEMENT OF ORAL ANTICOAGULANTS IN CARDIAC SURGERY, WHEN IS THE OPTIMAL STOP TIME

49. EVALUATION OF NOVEL ORAL ANTICOAGULANT PRESCRIPTION PATTERNS IN A TERTIARY CARE CLINIC

Catalog

Books, media, physical & digital resources